Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI

por Sims, Matthew, Berenson, Charles, Cohen, Stuart, Wang, Elaine, Hohmann, Elizabeth, Nathan, Richard, Odio, Alberto, Cook, Paul, Brady, Kelly, Lombardi, David, Memisoglu, Asli, De, Ananya, Hasson, Brooke, Lashner, Bret, Korman, Louis, Grimard, Doria, Gutierrez, Juan Carlos Moises, McGovern, Barbara, Moltke, Lisa Von
Publicado 2023